Endothelial dysfunction has important prognostic implications in these groups of patients.62,63 Blocking the RAS with AT1 receptor antagonists clearly ameliorates endothelial dysfunction, an effect that is not totally dependent on BP reduction. Here, AGTR1 is linked to endothelial dysfunction.